Significantly higher protein expression of EZH2 was also observed for patients with T3–T4 tumor stage compared to those with T1–T2 (p = 0.004) as well as in presence of nodal (p = 0.008) and distant metastases (p < 0.001) (Table 3 and Figure 1D). Here, EZH2 is linked to neoplasm.